Innovations that reach the patient: early health technology assessment and improving the chances of coverage and implementation

With growing concerns for the sustainability of the financial burden that health care-and especially cancer services-poses on the national budgets, the role of health economic analyses in coverage decisions is likely to grow. One of the strategies for the biomedical research field-also in oncology r...

Full description

Saved in:
Bibliographic Details
Published in:Ecancermedicalscience 2016-10, Vol.10, p.683-683
Main Authors: van Harten, W H, Retèl, V P
Format: Article
Language:English
Subjects:
Biomedical research
Breast cancer
Cancer therapies
Cost analysis
Health insurance
Innovations
Insurance agencies
Insurance coverage
Leadership
Melanoma
Professionals
Proposals
Short Communication
Technological change
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:With growing concerns for the sustainability of the financial burden that health care-and especially cancer services-poses on the national budgets, the role of health economic analyses in coverage decisions is likely to grow. One of the strategies for the biomedical research field-also in oncology research-to foster coverage and health system implementation, is to anticipate this new role and to involve health technology assessment techniques earlier in various stages of translational research. In this article, we elaborate on the early involvement of health technology assessment in translational research and the concept of Coverage with Evidence Development in The Netherlands Cancer Institute and give two case examples that are currently ongoing: (1) tumour infiltrating lymphocytes therapy for metastatic melanoma; and (2) high-dose chemotherapy for BRCA1-like subgroup in triple-negative breast cancer. We conclude with recommendations for institutional policy.
ISSN:1754-6605
1754-6605
DOI:10.3332/ecancer.2016.683